American Pain Society and Pfizer Independent Grants for Learning and Change Launch Pain Research Grant Fund

Up to $2 Million Pledged by Pfizer for Multiple Research Proposals

Newswise — CHICAGO, April 13, 2016 – The American Pain Society (APS) today announced a new collaboration with Pfizer Independent Grants for Learning and Change (IGLC) to allocate up to $2 million to fund research grants focused on solutions to improve care for individuals with chronic pain.

APS and Pfizer IGLC seek to fund proposals that translate scientific knowledge into clinically useful approaches that improve the care of individuals with chronic pain, and achieve that translation while addressing one or more problems and objectives identified in the National Pain Strategy. Grant proposals should cover one of six domains identified in the National Pain Strategy. They are: population research, prevention and care, disparities, service delivery and payment, professional education and training, and public education and communication.

“With a diverse mission to advance the treatment of pain from multiple perspectives, the American Pain Society strongly supports the goals of the National Pain Strategy to increase funding for pain research and we are pleased to partner in this grant funding initiative,” said APS President Gregory Terman, M.D., Ph.D.

APS and Pfizer IGLC are issuing requests for proposals, and an APS Scientific Review Panel will review and evaluate submissions and make recommendations for the awards to the APS Steering Committee managing the RFP. The APS Steering Committee will make final grant decisions and Pfizer will fund the awards. Grants funded by Pfizer IGLC are the full responsibility of APS.

Organizations eligible to submit grant proposals include primary care professional associations, academic medical centers, health care systems or other inter-professional organizations. For information about proposal submissions, potential applicants should visit

About Pfizer Independent Grants for Learning and ChangeThe mission of Pfizer’s independent grant program is to improve the quality, safety and effectiveness of healthcare through facilitation and support of projects that increase the competence and performance of individual providers and healthcare teams, educate and empower their patients and implement practical solutions within systems of care.

About the American Pain SocietyBased in Chicago, the American Pain Society (APS) is a multidisciplinary community that brings together a diverse group of scientists, clinicians and other professionals to increase the knowledge of pain and transform public policy and clinical practice to reduce pain-related suffering. APS is the professional home for investigators involved in all aspects of pain research including basic, translational, clinical and health services research to obtain the support and inspiration they need to flourish professionally. APS strongly advocates expansion of high quality pain research to help advance science to achieve effective and responsible pain relief. For more information on APS, visit